Back to results
US 8,945,877 B2Granted
Polynucleotides encoding BMP-ALK3 antagonists
AssigneeAcceleron Pharma Inc.
InventorJasbir Seehra
Life of this patent
Estimating the term…
Abstract
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density and strength. In certain embodiments, the present invention provides ALK3 polypeptides, including ALK3-Fc fusion proteins.
Claims6
An isolated polynucleotide comprising a coding sequence for a polypeptide comprising the amino acid sequence of SEQ ID NO:7.
Dependencies are inferred from the claim text.